Search results
Exelixis (EXEL) Up 8.4% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo News· 8 months agoIt has been about a month since the last earnings report for Exelixis (EXEL). Shares have added...
Exelixis (EXEL) Gains 30% YTD on Cabometyx, Pipeline Progress
Zacks via Yahoo News· 8 months agoExelixis (EXEL) lead drug Cabometyx maintains momentum on consistent demand. Efforts to develop...
Festival Lumière: Gender parity is making up for lost time at film festivals
Euronews via Yahoo News· 9 months agoMore women have won top prizes at historic film festivals in the last six years than in six decades....
San Sebastian High-Tech Startup Challenge Wins: Witscript and Hyperate.io Now Vie for Up to $530,000...
Variety via Yahoo News· 10 months agoWitscript and Hyperrate.io took home the prizes at San Sebastian’s 5th Zinemaldia Startup Challenge...
CymaBay (CBAY) Stock Up on Positive Results From PBC Study
Zacks via Yahoo News· 10 months agoShares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it...
Exelixis' (EXEL) Prostate Cancer Study Meets Primary Endpoint
Zacks via Yahoo News· 11 months agoExelixis, Inc. EXEL and partner Ipsen announced that the late-stage CONTACT-02 study achieved one of...
Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo News· 1 year agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Why Is Exelixis (EXEL) Down 8.8% Since Last Earnings Report?
Zacks via Yahoo News· 2 years agoA month has gone by since the last earnings report for Exelixis (EXEL). Shares have lost about 8.8%...
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
Zacks via Yahoo News· 2 years agoEpizyme, Inc. EPZM incurred a loss of 21 cents per share in second-quarter 2022, narrower than the...
Sundance Prize Winner ‘President’ Banned in Zimbabwe for ‘Potential to Incite Violence’ (EXCLUSIVE)
Variety via Yahoo News· 2 years agoThe government of Zimbabwe has banned “President,” Danish filmmaker Camilla Nielsson’s...